UiPath Q2 Revenue Beats Expectations and Raises Full-Year Guidance; Stock Surges 13% After Hours Before Reversing to an 8% Drop
nashnova research
UiPath posted Q2 revenue of $410M, up 13% year-over-year and above consensus, while raising full-year guidance — yet the stock swung from +13% to −8% after hours, signaling the market wants more than steady improvement on the AI monetization story.
Revenue beat — so why did the stock reverse?
Revenue hit $410M, topping the Street's $398M estimate. Adjusted EPS came in at $0.15, exactly in line.
Shares spiked over 13% after hours, then gave back the entire gain and dropped roughly 8% as investors dug into the details.
This means → the market had already priced in a beat. What it really wanted was proof of accelerating growth — and this report said "steadily improving," not "inflection point."
ARR grew 12% — is that enough?
Annual recurring revenue — the subscription fees UiPath can count on each year — reached $1.938B, up 12% year-over-year.
Net-new ARR rose from $31M last quarter to $37M, a sequential improvement but still modest in absolute terms.
In plain terms = ARR is a software company's "base salary." A 12% growth rate means existing customers are renewing and new ones are signing, but the pace hasn't reached the acceleration stage that gets the market excited.
Management used a telling phrase: net retention is moving "upward in a steady fashion." This reflects a company managing expectations carefully — not ready to promise a breakout.
Big customers growing, small ones leaving?
Customers with ARR of $100K+ grew 10% year-over-year to 2,666. Those at $1M+ grew 21% to 387.
The company acknowledged that churn is concentrated among smaller accounts; the overall base is shifting toward large enterprises.
This means → UiPath's model is moving from "cast a wide net" to "land the big fish." Per-customer value is rising, but the engine for growing total customer count is weakening.
What role does AI actually play in UiPath's business?
CEO Daniel Dines disclosed that 18 of the top 20 deals this quarter included an AI component.
UiPath is repositioning itself as a "business orchestration platform" — weaving AI agents, bots, systems, and people together to run complex processes end-to-end.
Coding agents — AI tools that write automation code automatically — are cutting implementation workloads by nearly 60%, which could shorten the time customers need to see value.
In plain terms = the story UiPath wants to tell is "we're not just an automation tool — we're the control tower for AI-era workflows." But pricing models for agent products are still experimental, and AI-related revenue, while growing fast, lacks a standardized billing framework.
How much did guidance go up — and does the market care?
Full-year revenue guidance raised to $1.789B–$1.794B, up from $1.776B–$1.781B previously, and above the Street's ~$1.78B.
Full-year ARR guidance raised to $2.065B–$2.07B. Management said the company is on track to cross the $2B ARR milestone this fiscal year.
On a GAAP basis, UiPath posted its fourth consecutive quarter of profitability, with operating income of $32M and gross margin of roughly 84%.
This means → the guidance raise is roughly 1% above the prior range — not aggressive. That modest bump explains why the market "cooled down after reading the fine print."
What comes next?
Q3 guidance: revenue of $440M–$445M, ARR of $1.992B–$1.997B, both slightly above analyst estimates.
Leadership changes: Hitesh Ramani formally promoted to CFO; Brad Brubaker named Chief Legal & Administrative Officer; Yazdi Bagli, a Kaiser Permanente executive, joins the board.
The stock is up nearly 70% over the past 12 months but only about 12% year-to-date in 2026. This reflects lingering concern that AI could disrupt, not just enhance, software companies' revenue models.
Key dates: September 22 Investor Day + September 23–25 FUSION user conference — the market will be watching for AI product roadmap details and long-term financial targets. These events are the next real test of whether UiPath's AI monetization narrative can win investor conviction.
市场有风险，内容仅供研究参考，不构成投资建议。